Literature DB >> 3893813

The effect of extracorporeal antibody removal on antibody synthesis and catabolism in immunized rabbits.

B Charlton, K Schindhelm.   

Abstract

Plasma exchange therapy is currently used to remove antibody from the circulation in a number of autoimmune diseases. It has been suggested that the decrease in antibody level may affect synthesis rate by the removal of inhibitory feedback. This would then cause a rapid rise in antibody levels to or beyond those prior to depletion. Based on this supposition immunosuppression is nearly always used concomitantly with plasma exchange to prevent the expected increase in synthesis rates. An assessment of the effect of specific antibody removal by immunoadsorption on synthesis and catabolic rates was undertaken to clarify the nature of the response. Rabbits were immunized to bovine serum albumin (BSA) injected with 125I-anti-BSA IgG and later underwent extracorporeal immunoadsorption with BSA-Sepharose. At least 60% of circulating anti-BSA-IgG was removed. Mathematical analysis of 125I-anti-BSA IgG and anti-BSA-IgG levels demonstrated a reduction in catabolic clearance following immunoadsorption. Conversely synthesis rate was not altered. No significant overshoot of anti-BSA-IgG beyond pre-removal levels occurred. Based on these findings it is postulated that an increase in antibody synthesis does not generally occur following plasma exchange. The rise in antibody levels seen following plasma exchange probably reflect a reduction of catabolism combined with an unchanged rate of synthesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893813      PMCID: PMC1577210     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION.

Authors:  J L FAHEY; A G ROBINSON
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

2.  The theory of tracer experiments with 131I-labelled plasma proteins.

Authors:  C M MATTHEWS
Journal:  Phys Med Biol       Date:  1957-07       Impact factor: 3.609

Review 3.  Metabolism of immunoglobulins.

Authors:  T A Waldmann; W Strober
Journal:  Prog Allergy       Date:  1969

4.  Studies of 125I trace labeling of immunoglobulin G by chloramine-T.

Authors:  S Sonoda; M Schlamowitz
Journal:  Immunochemistry       Date:  1970-11

5.  Immunoglobulins in myasthenia gravis. Kinetic properties of the acetylcholine-receptor antibody studied during lymph drainage.

Authors:  A K Lefvert
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

Review 6.  Therapeutic plasmapheresis; present state and future aspects.

Authors:  H J Gurland; W Samtleben; M Blumenstein
Journal:  Life Support Syst       Date:  1983 Jan-Mar

7.  Protein A reactivity of various mammalian immunoglobulins.

Authors:  J Goudswaard; J A van der Donk; A Noordzij; R H van Dam; J P Vaerman
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

9.  Remission of myasthenia gravis following plasma-exchange.

Authors:  A J Pinching; D K Peters
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

10.  The kinetics of the distribution and breakdown of 1131-albumin in the rabbit. Observations on several mathematical descriptions.

Authors:  E B REEVE; J E ROBERTS
Journal:  J Gen Physiol       Date:  1959-11       Impact factor: 4.086

View more
  5 in total

1.  Extracorporeal immunoadsorption therapy on rats. In vivo depletion of specific antibodies.

Authors:  R Nilsson; L Lindgren; P Lilliehorn
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

Review 2.  Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.

Authors:  R P Junghans
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

3.  Immunoadsorption therapy for myasthenia gravis.

Authors:  N Shibuya; T Sato; M Osame; T Takegami; S Doi; S Kawanami
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

Review 4.  Radio-immunotherapy dosimetry with special emphasis on SPECT quantification and extracorporeal immuno-adsorption.

Authors:  S E Strand; M Ljungberg; J Tennvall; K Norrgren; M Garkavij
Journal:  Med Biol Eng Comput       Date:  1994-09       Impact factor: 2.602

5.  A comparison of the effects of plasma exchange and immunoadsorption on anti-insulin antibody synthesis in rabbits.

Authors:  B Charlton; G Antony; S G Cooper; K Schindhelm
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.